Don't underestimate the difficulty level of the Salesforce ALS-Con-201 certification exam because it is not easy to clear. You need to prepare real ALS-Con-201 exam questions to get success. If you do not prepare with actual ALS-Con-201 Questions, there are chances that you may fail the final and not get the ALS-Con-201 certification.
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
>> Trustworthy Salesforce ALS-Con-201 Dumps <<
All these three ALS-Con-201 real dumps formats contain the actual and updated Salesforce Certified Agentforce Life Sciences Consultant ALS-Con-201 exam questions that will surely repeat in the upcoming ALS-Con-201 exam and you can easily pass it with good scores. Today is the best time to learn new in-demand skills and upgrade your knowledge. Yes, you can do this easily. Just enroll in the Salesforce Certified Agentforce Life Sciences Consultant ALS-Con-201 Exam and start preparation with Salesforce Certified Agentforce Life Sciences Consultant ALS-Con-201 exam dumps. The updated, real, and verified Salesforce Dumps are ready for download. Just pay affordable Salesforce Certified Agentforce Life Sciences Consultant ALS-Con-201 exam dumps charges and get the exam dumps file in your mailbox and start ValidVCE ALS-Con-201 exam preparation.
NEW QUESTION # 106
Choose 1 option.
A field sales rep attempts to start a remote engagement session but receives an error indicating that they do not have permission to access the video service credentials. The rep's profile is verified in the Life Sciences Field Sales Representative permission set.
Which additional permission should an Agentforce Life Sciences Consultant assign?
Answer: A
Explanation:
Option A is correct because Remote Engagement with Twilio uses Salesforce named and external credentials, and users need access to the external credential principal to use those credentials. Salesforce Help for configuring Twilio credentials in Life Sciences Remote Engagement states that the Life Sciences Customer Engagement managed package includes the named and external credentials for Twilio. The same Salesforce Help result specifically references selecting External Credential Principal Access as part of the setup. This aligns directly with the error: the field sales rep cannot access the video service credentials, even though the Life Sciences Field Sales Representative permission set has been verified.
Option B is incorrect because the solution is not to manually provide the rep with a Twilio authentication token. That approach would be insecure and inconsistent with Salesforce's named/external credential model. Credentials should be managed centrally through Salesforce configuration, not distributed directly to end users. Option C is also incorrect because "Twilio Users Public Group" is not the documented permission mechanism for accessing the video service credentials in Life Sciences Cloud Remote Engagement.
Salesforce's broader named credential security documentation also explains that external credential principals can be mapped to permission sets and profiles so users can make callouts to external systems with the right access. That supports the need to grant External Credential Principal Access rather than changing the rep's profile or sharing tokens manually.
=========
NEW QUESTION # 107
Choose 1 option.
Cumulus Pharma wants to ensure a sample product is visible to field sales reps during a visit.
How should the Agentforce Life Sciences Consultant configure this?
Answer: C
Explanation:
The correct answer is C because sample visibility during visits depends on the product being configured as a Life Sciences Marketable Product with an appropriate distribution method. Salesforce Help for setting up Sample Inventory Management data states that, to designate a product as a sample product, administrators create a corresponding Life Science Marketable Product record. Salesforce's Life Sciences Cloud Developer Guide for LifeSciMarketableProduct identifies distribution methods such as Drop, DropAndShip, and Ship, which define how a product is distributed to a provider.
In a provider visit, a product must be configured as marketable and available for the relevant distribution method before reps can select it for sample drop-off. If the product is meant to be handed directly to the HCP during the visit, the distribution method must include Drop. If it can be either handed off during the visit or shipped, Drop and Ship is appropriate. This setup makes the product eligible for visit-based sampling workflows.
Option A is incorrect because permissions alone do not make a specific sample product visible. Reps may have access to sampling functionality, but the product still must be configured correctly. Option B is also incorrect because profile configuration in Visit Administration is not the key product-availability control. The essential configuration is the Life Sciences Marketable Product record with the correct distribution method. Therefore, the consultant should set the distribution method to Drop or Drop and Ship.
NEW QUESTION # 108
Choose 1 option.
An Agentforce Life Sciences Consultant is asked to configure strategic distribution limits for Immunexis 50mg in a high-growth territory. The business requirement mandates that the total quantity available for the territory in the next quarter is capped, and individual field sales reps are restricted from handing off more than 50 units in a single visit.
Which administrative configuration should the consultant recommend?
Answer: B
Explanation:
The correct answer is B because the requirement combines two controls: a territory-level cap for a product during a defined period and a per-visit disbursement limit for sales reps. Salesforce Life Sciences documentation for Territory Product Quantity Allocations states that these allocations are used to manage sample product distribution to healthcare professionals, and the setup guidance specifically references the Max Disbursement Limit Quantity as the maximum amount a sales rep can disburse in a given visit.
A Territory Product Quantity Allocation record is designed for the exact scenario described: controlling how much of a specific product is allocated to a territory and limiting how much can be disbursed during a visit. The consultant would define the allocated quantity for Immunexis 50mg for the high-growth territory for the next quarter and set the Max Disbursement Limit Quantity to 50 so that an individual field sales rep cannot hand off more than 50 units in one visit.
Option A is incorrect because setting a product-level maximum sample order quantity would apply too broadly across the organization and would not satisfy the territory-specific allocation requirement. Option C is not the best answer because an Advanced Sample Limit Template at the Healthcare Provider account level controls limits by HCP/account, not the total quantity available to a territory. Therefore, Territory Product Quantity Allocation is the correct administrative configuration.
NEW QUESTION # 109
Choose 1 option.
Cumulus Pharma uses Agentforce Life Sciences for Customer Engagement to provide Account Summaries. The Agentforce Life Sciences Consultant configured a Cross-Object Field History Graph to include related Provider Visit and Medical Inquiry records. Key Account Managers report that summaries include all related data; however, field sales reps report that their summaries exclude visit and inquiry data. Both user groups have Read access to the underlying objects.
What is the cause of this issue?
Answer: B
Explanation:
The correct answer is A because Account Summarization can use different Cross-Object Field History Graph assignments by org or profile. Salesforce Help for Life Sciences Account Summarization states that administrators can create a Cross-Object Graph for Account Summarization and assign cross-object graphs to an org or profile. Salesforce also describes the Account Summarization workflow as using configured cross-object field history so summaries can include recent and relevant account changes from related objects.
In this case, KAMs see summaries that include Provider Visit and Medical Inquiry records, while field sales reps do not. Both groups have Read access to the objects, so object permission is not the root cause. The difference is most likely profile-based summarization configuration: the graph containing Provider Visit and Medical Inquiry data has been assigned to the KAM profile but not to the field sales rep profile.
Option B is incorrect because Account Summary generation in this scenario is driven by Cross-Object Field History Graph configuration, not membership in a Data 360 segment. Option C is also incorrect because the question explicitly says both user groups have Read access. View All is not the stated requirement for using a graph in summarization. Therefore, the issue is that the Cross-Object Field History Graph is not assigned to the field sales rep profile.
=========
NEW QUESTION # 110
Choose 1 option.
A field sales rep performs an ad hoc inventory count for a controlled sample product. The rep enters a physical count of 95 units, while the system currently displays a balance of 100 units. The business requires that the system inventory records immediately reflect the physical reality to ensure an accurate audit trail.
How does Agentforce Life Sciences for Customer Engagement handle this discrepancy?
Answer: C
Explanation:
The correct answer is C because Salesforce Life Sciences Sample Inventory Management automatically adjusts the system count to match the actual count when an inventory-count discrepancy is recorded. Salesforce Help for Discrepancy Adjustments for Inventory Counts states that when a discrepancy is recorded in the inventory count, Sample Inventory Management adjusts the system count positively or negatively to match the actual count.
In this case, the physical count is 95 units, while the system balance is 100 units. The system must reflect the physical reality immediately for audit accuracy. Therefore, Life Sciences creates an adjustment transaction for the negative difference of 5 units so that the recorded inventory balance aligns with the counted quantity. This preserves the audit trail because the discrepancy is not silently overwritten; it is reconciled through an inventory adjustment transaction.
Option A is incorrect because a Product Request is used to request or replenish inventory, not to reconcile a counted discrepancy. The system should first record the loss or variance before any replenishment process is considered. Option B is also incorrect because locking the Product Item and triggering an assessment workflow is not the standard discrepancy reconciliation behavior described for inventory counts. The correct behavior is automatic generation of an adjustment transaction to reconcile the system balance with the physical count.
NEW QUESTION # 111
......
Our system is high effective and competent. After the clients pay successfully for the ALS-Con-201 study materials the system will send the products to the clients by the mails. The clients click on the links in the mails and then they can use the ALS-Con-201 Study Materials immediately. Our system provides safe purchase procedures to the clients and we guarantee the system won’t bring the virus to the clients’ computers and the successful payment for our ALS-Con-201 study materials.
Trustworthy ALS-Con-201 Pdf: https://www.validvce.com/ALS-Con-201-exam-collection.html